drugs for diarrhea and constipation Flashcards
opioid agonists
loperamide (immodium)
diphrenoxylate/atropine
octreotide
eluxadoline
opioid agonists MOA
activation of opioid receptors in the smooth muscle of the GI tract - alters peristalsis by preventing smooth muscle contraction and relaxation - reduces stool volume and prevents electrolyte depletion
what do you need to correct prior to use of opioid agonists
fluid/electrolyte imbalances
dont use opioid agonists in
toxic megacolon or infectious diarrhea
loperamide MOA
increases IAS and EAS
loperamide metaboolism
hepatic
loperamide excretion
fecal
loperamide side effects
constipation - dizziness, abd pain, cramping
loperamide black box warning
cardiac arrest when used in large doses - CNS effects
cannot give loperamide in pts with
QT prolongation
diphrenoxylate/atropine MOA
contains small amount of atropine to prevent abuse
diphrenoxylate/atropine onset
45 min
diphrenoxylate/atropine metabolism
hepatic
diphrenoxylate/atropine excretion
fecal/urine
diphrenoxylate/atropine side effects
flushing, tachycardia, CNS effects, xeroderma, vomiting, toxic megacolon, urinary retention
diphrenoxylate/atropine interactions
alcohol, CNS depressants, anticholinergic agents, azelastine, glucagon, prokinetic agents, eluxadoline, glycopyrrolate, opiods, kava kava, nitro, pot, zolpidem
octreotide MOA
inhibits serotonin release - inhibits secretion of gastrin, VIP, insulin, glucagon, motilin, and pancreatic polypeptide
octreotide duration
6-12 hrs
octreotide metabolism
hepatic